studerl Profile Banner
Lorenz Profile
Lorenz

@studerl

Followers
4K
Following
347
Media
17
Statuses
242

Stem cell biologist @MSKCancerCenter studying human PSCs for modeling development & disease and for cell therapy. Opinions are my own and do not represent MSK.

New York, NY
Joined March 2009
Don't wanna be here? Send us removal request.
@MSKCancerCenter
Memorial Sloan Kettering Cancer Center
5 months
Dr. @TabarViviane and Dr. @studerl, physician-scientists at MSK, have developed a treatment for #Parkinson’s disease that involves creating nerve cells from embryonic stem cells and transplanting them into patients. Early results show the treatment is safe and may improve
1
18
52
@lydfinley
Lydia Finley
7 months
Things I wish more people knew about doing science in the US (thread):
15
266
700
@studerl
Lorenz
10 months
Congrats to @ZeltnerLab on their new paper. Genipin rescues developmental and degenerative defects in familial dysautonomia models and accelerates axon regeneration | Science Translational Medicine https://t.co/vhjSE8Qthf. It was exciting to see this story develop from way back.
Tweet card summary image
science.org
Genipin rescues developmental and degenerative phenotypes of the peripheral neuropathy familial dysautonomia and enhances neuron regeneration.
0
2
26
@MSKCancerCenter
Memorial Sloan Kettering Cancer Center
11 months
👏 Congratulations to Dr. Deb Schrag, Chair of the @MSK_DeptOfMed, and Dr. @studerl, Director of the Center for Stem Cell Biology at MSK, who were elected to the @theNAMedicine, one of the highest honors bestowed upon scientists worldwide. Learn more: https://t.co/N2NdRJv4TE
Tweet media one
Tweet media two
8
20
99
@DanweiHuangfu
Dr. Danwei Huangfu
11 months
📢 Join us! Developmental and stem cell biologists, checkout our tenure-track faculty position at Sloan Kettering. Apply by October 18. #DevBio #StemCell #hiringnow https://t.co/9h9gl6EZEe
Tweet card summary image
mskcc.org
The Sloan Kettering Institute is seeking innovative scientists to join our faculty.
0
26
72
@studerl
Lorenz
11 months
This was a great episode indeed. Congrats to @bigosi and @TabarViviane
@stemcellpodcast
Stem Cell Podcast
1 year
🥇 The top spot goes to Drs. Stefan Irion (@bigosi) and Viviane Tabar (@TabarViviane)! This episode was recorded live at @BlueRockTx and focuses on bemdaneprocel — a stem cell-derived investigational cell therapy for Parkinson’s disease! #InternationalPodcastDay
Tweet media one
0
3
23
@stemcellpodcast
Stem Cell Podcast
1 year
Congratulations to Dr. Shuibing Chen (@ChenShuibing) on her lab's new @CellStemCell paper! Her team developed vascularized macrophage-islet #organoids to study damage from infection. Read the article: https://t.co/3n4X8STm5p Learn more about her work 👇
Tweet card summary image
stemcellpodcast.com
Dr. Shuibing Chen is the Kilts Family Professor of Surgery at Weill Cornell Medicine. Her lab uses hiPSCs and ESCs for disease modeling and drug screening, with a focus on diabetes and infectious...
1
4
22
@studerl
Lorenz
1 year
Exciting opportunity for open tenure track positions in Developmental Biology & Stem Cell Biology @MSKCancerCenter (see Ad - https://t.co/BxutHyvFn1). Deadline for applications is October 14, 2024 ( https://t.co/8SJujIBPP0)
Tweet card summary image
nature.com
Sloan Kettering Institute (MSK) invites applications for junior tenure-track faculty positions in the Development Biology Program...
0
54
90
@studerl
Lorenz
1 year
Great postdoc opportunity if you are interested in developing next gen human PSC based cell therapies for brain repair here at MSK
@TabarViviane
Viviane Tabar
1 year
We have a postdoc opportunity to work on cell therapy for #Parkinson’s disease in a highly collaborative environment @MSKCancerCenter @MSKEducation Apply at
0
10
25
@studerl
Lorenz
1 year
Excited to see the work published @Nature. Excellent summary in thread below. Big collaborative effort with @ShenYingZhang1, @casanova_lab + many more. Special thanks to @yihaoo, @ZhiyongLiu7, Paul Bastard and in my lab @NoopurKhobrekar, Param Amin, @gabriele_ciceri & @harschnitz
@ShenYingZhang1
Shen-Ying Zhang
1 year
1) Just out @Nature today! We show that human TMEFF1 is a restriction factor for #Herpes simplex virus 1(HSV1) in the brain, by limiting NECTIN1—HSV1-gD mediated HSV1 entry into cortical neurons. TMEFF1 defect can underlie HSV1 #encephalitis. https://t.co/ESeorkXBGC
Tweet media one
0
5
31
@studerl
Lorenz
1 year
Excellent thread from @ShenYingZhang1 on this new collaborative story, and for our lab one of the first studies to test run new hindbrain neuron protocol developed by @harschnitz
@ShenYingZhang1
Shen-Ying Zhang
1 year
(1) We are happy to share our new study, “SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency” @JExpMed! https://t.co/WIRWBLH9RJ. Accumulation of RNA lariats results in impaired antiviral immunity in hPSC-derived hindbrain neurons, underlying encephalitis.
0
6
24
@NatSaurat
Nathalie Saurat
1 year
Look, it’s the @studerl lab past and present at #ISSCR2024. Getting together is another awesome part of attending this conference 🤩
Tweet media one
1
8
69
@studerl
Lorenz
1 year
Super excited to see this study finally published after many years of work. Congrats to @NatSaurat for the heroic effort and to all the many amazing collaborators who made this work possible. Also big thanks to our funders particularly the JPB foundation, NIA and @ASAP_Research.
@studerl
Lorenz
1 year
How to trigger age-related features in hPSC neurons? In a CRISPR screen @NatSaurat identified neddylation inhibition as a tool to trigger hallmarks of aging in neurons and selective degeneration in AD or PD but not isogenic control neurons. @cellstemcell https://t.co/vycsfPED6g
Tweet media one
1
13
78
@studerl
Lorenz
1 year
How to trigger age-related features in hPSC neurons? In a CRISPR screen @NatSaurat identified neddylation inhibition as a tool to trigger hallmarks of aging in neurons and selective degeneration in AD or PD but not isogenic control neurons. @cellstemcell https://t.co/vycsfPED6g
Tweet media one
1
46
145
@studerl
Lorenz
1 year
Excellent thread from @_SoyeonKoo on the paper (and also her thesis work 😊). Congrats!
@_SoyeonKoo
So Yeon Koo
1 year
Excited to share that my doctoral thesis work is out in @CellCellPress We investigated a molecular driver to trigger hPSC-derived midbrain dopamine neurons during engraftment in mice.
0
2
12
@LabWaggoner
Waggoner Lab
1 year
@CellCellPress @TaeWanKim0 @studerl Transient TNF-α inhibition overcomes a p53-dependent survival restriction in grafted dopamine neurons as a clinically relevant strategy to promote functional dopamine neuronal engraftment in Parkinson’s disease
0
3
6
@TommyVierbuchen
Thomas Vierbuchen
1 year
Excited to share our latest paper led by @rachelaglenn. We generated a genetically diverse mouse pluripotent stem cell panel from the Diversity Outbred stock and outline experimental approaches for "population-scale" in vitro directed differentiation. https://t.co/hYkW2fJ1qo
Tweet card summary image
biorxiv.org
The directed differentiation of pluripotent stem cells (PSCs) from panels of genetically diverse individuals is emerging as a powerful experimental system for characterizing the impact of natural...
3
27
59
@studerl
Lorenz
1 year
Why do most dopamine neurons die shortly after transplantation and how can we fix it? Excited to see our story out at Cell. Congrats to @TaeWanKim0 & SoYeon Koo @MSKCancerCenter and to all the other collaborators who made this work possible.
Tweet card summary image
cell.com
Transient TNF-α inhibition overcomes a p53-dependent program that restricts the survival of grafted dopamine neurons and offers a clinically relevant strategy to enhance survival and promote functi...
4
48
156
@studerl
Lorenz
1 year
Excellent to hear that the FDA gave RMAT designation to DA-01 (Bemdaneprocel) following the promising 18-month data in 12 patients from the BlueRock-sponsored dopamine neuron cell therapy trial in advanced PD – see also article below and BR press release
bluerocktx.com
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease 
@parkinsonstory
Parkinson's News Today
1 year
The FDA granted regenerative medicine advanced therapy (RMAT) designation to bemdaneprocel, a therapy being developed for Parkinson's. https://t.co/hMQCl280T2
Tweet media one
0
10
43